
CMS recognizes the NCCN compendium as a source for determining whether a cancer drug or biologic should be covered.
CMS recognizes the NCCN compendium as a source for determining whether a cancer drug or biologic should be covered.
A study from the Office of the Inspector General of the department of Health & Human Services finds problems for dual-eligible residents of nursing facilities with Medicare Part D.
The feds have issued two guidances related to the use of drugs for the influenza pandemic.
Two letters signeed by 132 members of Congress urge a delay in the Medicare bidding program for home medical equipment.
The Centers for Medicare and Medicaid Services is offering hardship payments for providers with cash flow problems related to the National Provider Identification numbers.
A demonstration is planned today in Manhattan to protest against cuts in drug reimbursement that take effect on July 1.
The Centers for Medicare & Medicaid Services has turned down a proposal from Louisiana to increase the state's Medicaid dispensing fee to more than $10.
The state of Connecticut has joined in the class-action suit against McKesson, First DataBank, and Medi-Span over inflated average wholesale prices.
The agency releases alert to transition patients to new albuterol inhalers by year's end.
A new settlement has been proposed in the average wholesale price suit against First DataBank, McKesson, and Medi-Span.
The Ohio Board of Pharmacy is investigating the Cardinal distribution center in Findlay, Ohio, for distributing large amounts of controlled substances to an Internet pharmacy.
Two former CVS executives have been acquitted of bribing a Rhode Island state senator for legislative favors.
Three Miami area doctors and six others were charged for defrauding Medicare.
A California man faces incarceration and a hefty fine for selling drugs over the Internet without the proper safeguards in place.
CMS issues a final rule letting researchers and HHS access Part D claims data for research purposes.
SEI Pharmaceuticals' Xiadafil VIP Tabs are being recalled for containing a substance that could hurt patients.
Express Scripts has agreed to pay 28 states and the District of Columbia $9.3 million to settle charges that it switched cholesterol-lowering drugs for financial gain.
CMS will need more time before it issues a final rule on conditions for hospices to participate in Medicare and Medicaid.
A California man faces incarceration and a hefty fine for selling drugs over the Internet without the proper safeguards in place.
FDA warns about the dangers in Mommy's Bliss Nipple Cream.
The City of San Francisco is suing McKesson in federal court, alleging that the wholesaler conspired to inflate the gap between wholesale acquisition costs and average wholesale prices.
The results of 13 focus groups on Medicare Part D have been compiled into a report for MedPAC.
Because Scientific Laboratories' products are not approved or have not met good manufacturing practices, FDA is barring them from being sold.
Consumers Union is urging the FDA to move ahead with requiring TV ads for Rx drugs to include a toll free number and a Web site address to report serious side effects from presciption drugs.
An expert gives drug plans advice on how to pass a Medicare Part D audit
Several lots of Doxil, Procrit, and Remicade have been stolen, prompting the manufacturers to issue a voluntary withdrawal of the lots affected.
A new Pennsylvania law sets up a voluntary drug repository program for cancer patients.
FDA is holding a meeting, launching a pilot, and releasing a concept paper about drug names next month.
Oklahoma pharmacies can now renew their narcotic registration electronically.
The Centers for Medicare & Medicaid Services has added new critiera hospitals must meet in order to get optimal reimbursement